Veronica Byfield Sköld
Chief Executive Officer at BioLamina AB
Veronica Byfield Sköld active positions
| Companies | Position | Start | End |
|---|---|---|---|
BioLamina AB
 BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Chief Executive Officer | 2021-09-30 | - |
| Director/Board Member | 2021-03-31 | - |
Career history of Veronica Byfield Sköld
Former positions of Veronica Byfield Sköld
| Companies | Position | Start | End |
|---|---|---|---|
| CLEMONDO GROUP AB | Sales & Marketing | 2020-07-31 | - |
Training of Veronica Byfield Sköld
| Royal Institute of Technology | Graduate Degree |
| IHM Business School AB | Undergraduate Degree |
Statistics
International
| Sweden | 5 |
Operational
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
| Graduate Degree | 1 |
Sectoral
| Consumer Services | 3 |
| Health Technology | 2 |
| Consumer Non-Durables | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| CLEMONDO GROUP AB | Consumer Non-Durables |
| Private companies | 1 |
|---|---|
BioLamina AB
BioLamina AB BiotechnologyHealth Technology BioLamina AB develops, manufactures and markets cell culture reagents intended for culturing of primary cells. Its applications animal stem cells, cancer cells, cardiac applications, clonal applications, endothelial applications, epithelial applications, expansion of human PSC, eye applications, hepatic applications, intestinal applications, kidney cell culture, lung applications, neural applications, pancreatic applications and skeletal muscle applications. The company was founded by Kristian Tryggvason and Karl Tryggvason in 2008 and is headquartered in Sundbyberg, Sweden. | Health Technology |
